Research at Keele Discovering Excellence | Page 12

Professor Paul Eggleston Discovering Excellence | Malaria Malaria Centre for Applied Entomology and Parasitology Malaria, Mosquitoes and Man: Keele University Research Team targets devastating global disease Malaria is an important disease that afflicts the health and socioeconomic development of half the world’s population In 2005, a global alliance of over 500 governments, non-governmental organisations, commercial companies and private sponsors combined to form the Roll Back Malaria Partnership with the aim to scale-up control measures, ensure their sustained delivery and, by 2015, ensure that malaria is no longer a major cause of global mortality nor a barrier for socioeconomic development. While there has been some successes, these are jeopardised by worrying new reports of treatment failure with the current front-line antimalarial drugs and evolving resistance in mosquitoes to insecticides. Keele University’s Centre for Applied Entomology and Parasitology hosts a cluster of five research teams that have parallel interests in understanding the pathology of disease and developing strategies for the control of malaria. Termed ‘Malaria, Mosquitoes and Man’ or MMM, this cluster has had some considerable success over recent years in securing external research funding and has developed new research links with colleagues in Western Africa. In addition, MMM recruits and trains scientists, many from malaria endemic countries, in the use of modern molecular techniques. Located within the Huxley Building on the main University campus, MMM is housed within large, modern multi-user laboratories to facilitate sharing of ideas, resources and equipment. Researchers have access to specialist insect-rearing facilities and a secure facility to maintain parasite cultures. 11 Malaria is a disease caused by a unicellular parasitic organism that is spread between human hosts through the bite of a mosquito. The research carried out by the MMM cluster addresses the biology of the parasite, the pathogenesis of disease in humans and the transmission of the malaria parasite by mosquitoes. Dr Paul Horrocks and Dr Catherine Merrick are investigating the biology of the most virulent species of the malaria parasite, Plasmodium falciparum. They are interested in the molecular mechanisms that control growth inside human red blood cells, and also in how these infected red blood cells persist in the face of the immune response and how this process can be subverted to cause disease. Both Paul and Catherine are supported by New Investigator Awards from the Biotechnology and Biological Sciences Research Council and Medical Research Council, respectively. Paul also works with Dr Mark Skidmore to explore the potential of chemically-modified complex carbohydrates as a novel adjunct therapy to support more traditional small-molecule antimalarial therapies. Dr Srabasti Chakravorty, meanwhile, focuses directly on the interaction of the malaria parasite with the human host. Parasitized red blood cells can accumulate in blood vessels within the brain, often resulting in coma and death. Srabasti is interested in understanding how this accumulation alters the cells that line the blood vessels and how this then goes on to affect the blood-brain barrier. The MMM team is also interested in the biology of the mosquito and its complicated interactions with the malaria parasite. They believe that releasing genetically-modified mosquitoes, which kill parasites ingested during a blood meal, may be an effective means of biological control in malaria endemic regions. This creates many challenges; including whether engineered mosquitoes are ‘fit’ enough to persist in the wild and produce a sustained control effect. An important part of this research is collaborations with African scientists. In one programme, funded by the Wellcome Trust, Professor Paul Eggleston and Dr Frederic Tripet collaborate with researchers at the Malaria Research and Training Centre at the University of Bamako in Mali. As well as training three Malian scientists at Keele, they have established a modern secure research laboratory in Mali to develop and translate these novel control approaches to the ‘field’. In a second capacity-building programme funded by the Medical Research Council, Frederic is working with colleagues in Burkina Faso to seek an understanding of the ecology, population genetics and mating behaviour of local mosquito populations. This information is vital for the future release of genetically-modified or sterile mosquitoes.